Startup · $1m raised
Melbourne, VIC
Every investor coverage indicates participated in a round Deftbiotech raised.
| Investor | Rounds | Invested |
|---|---|---|
| Breakthrough Victoria | Pre-seed | $500,000 |
| Eagle Fund | Pre-seed | $500,000 |
| La Trobe University | Pre-seed | $500,000 |
Companies Deftbiotech acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.
| Name | Role | Sources |
|---|---|---|
| Adrienne Clarke | Emeritus Professor, Chairperson | Breakthrough Victoria (Fri 27 Mar 2026), Startup Daily, SmartCompany, Breakthrough Victoria (Thu 19 Mar 2026) |
| Dr Susan Lachal | Founder | Startup Daily, SmartCompany |
| Professor Marilyn Anderson | Emeritus Professor, CEO | Breakthrough Victoria (Fri 27 Mar 2026), Startup Daily, SmartCompany, Breakthrough Victoria (Thu 19 Mar 2026) |
Stories naming Deftbiotech. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
La Trobe University opened its Eagleworks Innovation Centre, home to the $18m Eagle Fund co-funded with Breakthrough Victoria, part of the $100m University Innovation Platform.
A roundup of three raises: Advanced Navigation's $158 million Series C, legal AI platform MiAI Law's $2 million launch funding, and Deftbiotech's $1 million pre-seed for a fungal nail treatment.
Melbourne biotech Deftbiotech secures $1 million combined investment from Breakthrough Victoria and La Trobe University's Eagle Fund to develop a topical nail fungus treatment.